Previous reports have shown an improvement of insulin action and amelioration of insulin resistance after C21 treatment in different rodent models of insulin resistance and type 2 diabetes, including KK‐Ay diabetic mice (Ohshima et al. This evidence concerns the gene INS and type 2 diabetes mellitus.